MedPath

Early Prevention of Post Traumatic Stress Disorder

Not Applicable
Completed
Conditions
Post Traumatic Stress Disorder
Interventions
Behavioral: Intervention
Other: Treatment as usual
Registration Number
NCT02004743
Lead Sponsor
Sunnybrook Health Sciences Centre
Brief Summary

Sunnybrook Health Sciences Centre is Canada's largest trauma centre, treating 1,100 patients annually. A traumatic experience can lead to post-traumatic stress disorder, which increases hospital stays, emergency visits and disability. Despite developing leadership to manage a "Code Orange" mass trauma, Sunnybrook lacks guidelines in the psychological management of patients who have experienced trauma. The department of psychiatry currently holds a Traumatic Brain Injury clinic and PTSD services for youth but lacks both immediate intervention, prevention and adult services. This research will enable us to gain best evidence expertise to develop guidelines as well as a sustainable PTSD treatment program, with clear outcomes to assess effectiveness, psychiatric morbidity, use of healthcare, disability and substance abuse.

The five world-expert-consensus intervention resilience based principles will be operationalized in guidelines for the management of trauma patients, their caregivers and in routine nursing and trauma team care from the Emergency to the ward, and discharge, through to outpatient care. It is hypothesized that this will improve the psychological recovery of patients at risk of developing PTSD after a traumatic injury. In addition, early screening and intervention for increased risk of PTSD will be implemented one month after the trauma. It is hypothesized that such trauma informed psychological management, early screening and expert treatment using prolonged exposure will reduce hospital stays, functional disability, as well as longer-term psychiatric morbidity, including substance abuse.

Detailed Description

The study is a longitudinal interventional study, with a control group who have treatment for their trauma with no guidelines for psychological management, staff training, patient and family intervention/education. In the intervention group, who will have all of the above, participants will be stratified according to risk factors for PTSD and randomized 1:1 in "low risk" and "at risk" groups-those who will have a prolonged exposure intervention and those who will not.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • undergone severe physical trauma within the last 3 days
  • An abbreviated Injury Severity score of 1-3
Exclusion Criteria
  • 14 years of age or younger
  • an inability to communicate sufficiently in English
  • A diagnosis of psychosis, mental retardation and/or autism

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionInterventionPsychological management guidelines + patient education
ControlTreatment as usualTreatment as Usual
Primary Outcome Measures
NameTimeMethod
Depressive symptomsrecruitment, 1 month, 3 months & 6 months

The Beck Depression Inventory - Second Edition (BDI-II) will be used at recruitment, 1 month, 3 months, and 6 months follow-up to measure the presence and/or change in depressive symptoms of the patient.

Presence & severity of PTSD symptoms1 month, 3 months & 6 months

The aim of the study is to observe whether there's a presence and severity (if applicable) of Posttraumatic symptoms in patients who've received the intervention, compared to those who have not.

Presence and severity of PTSD symptoms will be measured by:

* follow-up at 1 month, 3 months \& 6 months which involve specific PTSD self-report symptom measures: PTSD Symptom Scale

* Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorder (SCID) Semi-structured interview performed at 6 months either over the phone or in person

Secondary Outcome Measures
NameTimeMethod
Self-esteemrecruitment, 1 month, 3 months & 6 months

The Rosenberg Self-Esteem Scale (RSES) will be used at recruitment, 1 month, 3 months, and 6 months follow-up to measure any change in the patient's self-esteem over time.

Anxiety & dissociation symptomsrecruitment & 1 month

Patients will be assessed for anxiety and dissociation symptoms at recruitment and follow-up at 1 month with the Stanford Acute Stress Reaction Questionnaire (SASRQ).

Change in patient health & well-being6 months

The Short Form (36) Health Survey (SF-36v2) will be used at 6 months follow-up to assess a patient's health and/or disability.

Presence & severity of trauma related thoughts and beliefs1 month, 3 months & 6 months

follow-up at 1 month, 3 months \& 6 months which involve specific PTSD self-report symptom measures: The Posttraumatic Cogntions Inventory (PTCI)

Change in substance userecruitment, 1 month, 3 months & 6 months

PTSD is highly correlated with substance use. By implementing a preventative intervention, one aim is to reduce overall substance use. This will be assessed using the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Abuse Screening Test (DAST) at recruitment, 1 month, 3 months and 6 months.

Locus of Controlrecruitment, 1 month, 3 months & 6 months

The Internal Control Index (ICI) will be used at recruitment, 1 month, 3 months, and 6 months follow-up to measure any changes with a patient's Locus of Control, the extent to which they feel they can control the events that occur to them.

Self-efficacyrecruitment, 1 month, 3 months & 6 months

The Self-Efficacy Scale will be used at recruitment, 1 month, 3 months \& 6 months follow-up to asses any changes in a patient's self-efficacy/personal competence.

Trial Locations

Locations (1)

Sunnybrook Health Sciences Center

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath